Who Won It

Contract award · 19 Jan 2021

Hepatitis B immunoglobulin intravenous use (IV)

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded “Hepatitis B immunoglobulin intravenous use (IV)” to Biotest (UK) Ltd for £44,000 on 19 Jan 2021. Awarded without open competition.

No competitionMedical equipment & pharmaceuticalsScotland

BuyerThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Value £44,000
WinnerBiotest (UK) Ltd SME

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · Body governed by public law
Supplier
Biotest (UK) Ltd SME
Value
£44,000
Procedure
Award procedure without prior publication of a call for competition
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Official notice
002597-2021 on Find a Tender
Timeline
  1. Contract date19 Jan 2021
  2. Published9 Feb 2021Published 21 days after the contract date

Description

Supply of Hepatitis B immunoglobulin intravenous use (IV) to the Scottish National Blood Transfusion Service (SNBTS), Edinburgh, for use by health boards across Scotland

About the supplier

More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview